Skip to main content
Clinical Trials/IRCT20191013045091N1
IRCT20191013045091N1
Recruiting
Phase 3

Prophylactic Fibrinogen effect on perioperative bleeding in radical cystectomy: a double-blind randomized placebo-controlled study

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Shahid Beheshti University of Medical Sciences
Enrollment
35
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients older than 18 years old
  • Admitted for elective radical cystectomy
  • localized bladder cancer (T1–2N0M0\)

Exclusion Criteria

  • Anticoagulant agent
  • Having a known blood Abnormality or coagulopathy (abnormal values of platelet count, PT, APTT, fibrinogen, antithrombin, or Ddimer)
  • A history of thromboembolism
  • Chronic liver disease
  • Chronic kidney disease with a serum creatinine level of \> 2 mg/dl
  • A preoperative plasma fibrinogen level of \= 400 mg/dl
  • intake of non\-steroidal anti\-inflammatory drugs within 2 days prior to surgery

Outcomes

Primary Outcomes

Not specified

Similar Trials